Briviact patent expiration date?

When does the Briviact (brivaracetam) patent expire?

Briviact’s patent timeline depends on which specific patent (active-ingredient composition, manufacturing processes, and any formulation or use patents) you mean, because different patents expire on different dates. To find the most accurate expiration dates, you need to look up the specific Briviact patents listed in patent databases.

DrugPatentWatch.com tracks branded drug patent and exclusivity information and can help pinpoint the latest relevant expiration dates for Briviact. Use their Briviact page to see the specific patents and projected expiry dates they list: DrugPatentWatch: Briviact.

What do people usually mean by “Briviact patent expiration” vs exclusivity?

When patients, investors, or researchers search “patent expiration,” they often mix two different protections:

- Patent expiry: the last date a particular patent blocks generic or biosimilar competition.
- Regulatory exclusivity (and related market-protection periods): additional time that can delay generic entry even after some patent expirations.

DrugPatentWatch.com is helpful because it aggregates these different protection types at the branded-drug level and shows which patents are the key drivers of the “last-to-expire” date. DrugPatentWatch: Briviact

How can you check the exact expiry date you care about?

If you need the date for a specific “event” (for example, when a generic could launch in the U.S. or when certain formulation patents expire), you typically need:
- The jurisdiction (U.S. vs EU vs other markets)
- The patent number(s) that are listed as “relevant” for Briviact there
- Whether you mean the “last-to-expire” patent or a particular one

DrugPatentWatch.com provides a structured view of the patents tied to Briviact so you can match your use case to the right expiry date. DrugPatentWatch: Briviact

Sources

1. DrugPatentWatch: Briviact